Financial News
Latest News about BofA Securities
Recent news which mentions BofA Securities
BofA Downgrades Ionis After Vupanorsen Setback: Are There Upcoming Catalysts That Can Help The Stock?
February 01, 2022
Tickers
IONS
From Benzinga
Why BofA Sees 'Better Entry Point' In Ginkgo Bioworks Stock
January 28, 2022
Tickers
DNA
From Benzinga
BofA Expecting Earnings Beat From GM, But Misses From Ford And Tesla: What Investors Need To Know
January 25, 2022
From Benzinga
Why This BofA Securities Analyst Is Cutting Airline Price Targets
January 24, 2022
From Benzinga
5 Reasons Blue Owl Capital Should Generate Strong Earnings Growth
January 24, 2022
Tickers
OWL
From Benzinga
Why This Analyst Has Increased Confidence In Inovio Pharmaceuticals
January 21, 2022
Tickers
INO
From Benzinga
From Benzinga
6 Analysts Dissect Microsoft's Activision Blizzard Deal: 'A Call Option On Numerous Metaverse Plays'
January 19, 2022
From Benzinga
Why This Analyst Is Worried About Opendoor's iBuying Model In 2022
January 19, 2022
Tickers
OPEN
From Benzinga
Why This Tesla Analyst Is Projecting Sharp Drop In Market Share, Benefits For Legacy Automakers
January 19, 2022
From Benzinga
Are Netflix Shares Headed To $750?
January 18, 2022
From Benzinga
BofA Bullish On This Gene Therapy Biotech Transitioning Into A Commercial Enterprise
January 18, 2022
Tickers
KRYS
From Benzinga
From Benzinga
BofA Initiates Coverage Of Krispy Kreme With A Buy, Says Company Can More Than Double Access Points
January 11, 2022
Tickers
DNUT
From Benzinga
From Benzinga
From Benzinga
Singular Genomics G4 Launch Impresses BofA Analyst: What's Next?
January 07, 2022
Tickers
OMIC
From Benzinga
From Benzinga
What Is Coinbase Doing That Caused BofA To Upgrade The Stock?
January 06, 2022
Tickers
COIN
From Benzinga
Why This Pfizer, Regeneron Analyst Has Contrasting Recommendations For The COVID Stock Plays
January 05, 2022
From Benzinga
From Benzinga
Holiday Streaming Wars: ViacomCBS, Spotify Impress In December, While Disney And Netflix Downloads Drop
January 04, 2022
From Benzinga
From Benzinga
How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?
December 23, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
